Delivery Order #SPE2D326F7738

Delivery Order for Ketorolac Vials under Fresenius Kabi Indefinite Delivery Contract

This award represents a delivery order contract issued under an existing indefinite delivery/indefinite quantity (ID/IQ) contract with Fresenius Kabi, LLC, a leading provider of pharmaceutical products. The specific procurement involves Ketorolac 30 mg/ml vials, essential injectable pain management medication, supplied to support U.S. Department of Defense medical readiness. The contract is a short-term, task-specific delivery order reflecting the ongoing relationship established by a prior substantial ID/IQ contract which secured critical medical supplies for military healthcare. This award, conducted competitively through the original indefinite contract acquisition, ensures timely replenishment of a key pharmaceutical product. Performance of this delivery order is scheduled over a narrow timeframe in 2026 at the place of performance in Lake Zurich, Illinois. While financial amounts for this delivery order are modest, it plays a vital role in fulfilling the broader objectives of sustaining medical preparedness for defense personnel. No subcontractors were reported for this specific order. The seamless execution of this delivery order under the umbrella of the long-term contract highlights the continuous commitment to secure reliable and essential medical products for national defense healthcare needs.

Description

4571247401!KETOROLAC 30 MG/ML VIALML

View original record